Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Zamagni

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2017
Therapy assessment in multiple myeloma with PETCristina Nanni, Elena Zamagni
Blood Cancer Journal|December 7, 2017
MRD in multiple myeloma: more questions than answers?Philippe Moreau, Elena Zamagni
Blood|July 8, 2017
Toward a GEP-based PET in myelomaElena Zamagni, Michele Cavo
PET Clinics|May 16, 2019
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple MyelomaCristina Nanni, Elena Zamagni
Blood Advances|August 28, 2025
Fifteen year of use of functional imaging in multiple myeloma: where we started from and where are we goingElena Zamagni, Marco Talarico
British Journal of Haematology|August 14, 2012
The role of imaging techniques in the management of multiple myelomaElena Zamagni, Michele Cavo
Blood|November 2, 2021
How I treat high-risk multiple myelomaElena Zamagni, Simona Barbato, Michele Cavo
Blood|December 28, 2018
Imaging in multiple myeloma: How? When?Elena Zamagni, Paola Tacchetti, Michele Cavo
Hemasphere|March 21, 2022
Front-line treatment of multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Lancet (London, England)|June 7, 2021
Expanding CD38-targeting triplets for relapsed or refractory multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2017
Therapy assessment in multiple myeloma with PETCristina Nanni, Elena Zamagni
Blood Cancer Journal|December 7, 2017
MRD in multiple myeloma: more questions than answers?Philippe Moreau, Elena Zamagni
Blood|July 8, 2017
Toward a GEP-based PET in myelomaElena Zamagni, Michele Cavo
PET Clinics|May 16, 2019
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple MyelomaCristina Nanni, Elena Zamagni
Blood Advances|August 28, 2025
Fifteen year of use of functional imaging in multiple myeloma: where we started from and where are we goingElena Zamagni, Marco Talarico
British Journal of Haematology|August 14, 2012
The role of imaging techniques in the management of multiple myelomaElena Zamagni, Michele Cavo
Blood|November 2, 2021
How I treat high-risk multiple myelomaElena Zamagni, Simona Barbato, Michele Cavo
Blood|December 28, 2018
Imaging in multiple myeloma: How? When?Elena Zamagni, Paola Tacchetti, Michele Cavo
Hemasphere|March 21, 2022
Front-line treatment of multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Lancet (London, England)|June 7, 2021
Expanding CD38-targeting triplets for relapsed or refractory multiple myelomaMichele Cavo, Paola Tacchetti, Elena Zamagni
Pageof 20